Efficacy of repeat Isolated limb infusion with melphalan and actinomycin D for Recurrent melanoma

Cancer

Volumn 115, Issue 9, 2009, Pages 1932-1940

  Kroon, Hidde M ^a   Lin, D Yin ^a   Kam, Peter C A ^a,b   Thompson, John F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hypoxia; Isolated limb infusion; Limb salvage; Metastatic melanoma; Regional chemotherapy

Indexed keywords

DACTINOMYCIN; MELPHALAN;

ADULT; AGED; AMPUTATION; ARTICLE; BLISTER; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPARTMENT SYNDROME; CONTROLLED STUDY; DISTANT METASTASIS; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; ISOLATED LIMB INFUSION; LIMB SALVAGE; MALE; MELANOMA; MINIMALLY INVASIVE PROCEDURE; NAUSEA AND VOMITING; PANCYTOPENIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RECURRENT CANCER; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DACTINOMYCIN; DISEASE PROGRESSION; FEMALE; HUMANS; LEG; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; RECURRENCE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65749093124     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24220     Document Type: Article

References (35)

1. Vrouenraets B. C. Kroon B. B. R. Nieweg O. E. Thompson J. F. Isolated limb perfusion for melanoma: results and complications. In: Thompson J. F. Morton D. L. Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004:410-428. (Pubitemid 39463461)
2. Thompson J. F. Hunt J. A. Shannon K. F. Kam PC. Frequency and duration of remission after Isolated limb perfusion for melanoma. Arch Surg. 1997;132:903-907. (Pubitemid 27344144)
3. Vrouenraets B. C. Nieweg O. E. Kroon BB. Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg. 1996;83:1319-1328. (Pubitemid 26342147)
4. Vrouenraets B. C. Klaase J. M. Nieweg O. E. Kroon BB. Toxicity and morbidity of isolated limb perfusion. Semin Surg Oncol. 1998;14:224-231. (Pubitemid 28146514)
5. Thompson J. F. Kam PC. Current status of isolated limb infusion with mild hyperthermia for melanoma, Int J Hyperthermia. 2008;24:219-225.
6. Thompson J. F. Waugh R. C. Saw R. P. M. Kam P. C. A. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Reg Cancer Treat. 1994;7:188-192.
7. Thompson J. F. Kam P. C. Waugh R. C. Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998;l4:238-247. (Pubitemid 28146516)
8. Kroon H. M. Moncrieff M. Kam P. C. Thompson JF. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg. Oncol. 2008;15:3003-3013.
9. Lindner P. Thompson J. F. De Wilt J. H. Colman M. Kam PC. Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. Eur J Surg Oncol. 2004;30:433-439. (Pubitemid 38528929)
10. Wong J. H. Cagle L. A. Kopald K. H. Swisher S. G. Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol. 1990;44:146-150. (Pubitemid 20221427)
11. Grunhagen D. J. van Etten B. Brunstein F. et al. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol. 2005;12:609-615. (Pubitemid 41126090)
12. Noorda E. M. Vrouenraets B. C. Nieweg O. E. van Geel A. N. Eggermont A. M. Kroon BB. Repeat isolated limb perfusion with TNF-α and melphalan for recurrent limb melanoma after failure of previous perfusion. Eur J Surg Oncol. 2006; 32:318-324. (Pubitemid 44287670)
13. Thompson J. F. Kam PC. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. J Surg Oncol. 2004;l:88:81-83. (Pubitemid 38528929)
14. Wieberdink J. Benckhuysen C. Braat R. P. van Slooten E. A. Olthuis GA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982; 18: 905-910. (Pubitemid 13147887)
15. Lai D. T. M. Ingvar C. Thompson J. F. The value of monitoring serum creatine phosphokinase values following hyperthermic isolated limb perfusion for melanoma. Reg Cancer Treat. 1993;6:36-39. (Pubitemid 23287902)
16. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatments (WHO Offset Pub. No. 48). Geneva, Switzerland: World Health Organization; 1979.
17. Mann H. B. Whitney DR. On a test of whether 1 of 2 random variables is stochastically larger than the other. Ann Math Stat. 1947;18:50-60.
18. Kaplan L. Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1985;53:457-481.
19. Klaase J. M. Kroon B. B. R. van Geel A. N. et al. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg, 1994;178:564-572 (Pubitemid 24172563)
20. Strobbe L. J. Nieweg O. E. Kroon B. B. R. Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol. 1997;23:435-438. (Pubitemid 27491609)
21. McKay A. Byrne D. S. Recurrent limb melanoma: treatments other than isolated limb perfusion and infusion. In: Thompson J. F. Morton D. L. Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004:443-448.
22. Klop W. M. Vrouenraets B. C. van Geel B. N. et al. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg, 1996;182:467-472. (Pubitemid 26176477)
23. Bartlett D. L. Ma G. Alexander H. R. Libutti S. K. Fraker DL. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer. 1997;80:2084-2090. (Pubitemid 27506021)
24. Lienard D. Ewalenko P. Delmotte J. J. Renard N. Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992;10:52-60. (Pubitemid 23131785)
25. Lejeune FJ. High dose recombinant tumour necrosis factor administered by isolation perfusion for advanced tumours of the limbs; a model for biochemotherapy of cancer. Eur J Cancer. 1995;31A:1009-1016 (Pubitemid 26037425)
26. Hoekstra H. J. Schraffordt Koops H. de Vries L. G. E. van Weerden T. W. Oldhoff J. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer. 1993;72:1224-1229. (Pubitemid 23224990)
27. Bonenkamp J. J. Thompson J. F. de Wilt J. H. Doubrovsky A. de Faria Lima R. Kam PC. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. Eur J Surg Oncol. 2004;30:1107-1112. (Pubitemid 40267817)
28. Vaglini M. Ammatuna M. Belli F. et al. Evaluation of a second isolated perfusion for melanoma of the limbs. Melanoma Res. 1993;3:100.
29. Moller M. G. Lewis J. M. Dessureault S. Zager JS. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Int J Hyperther. 2008;24:275-289.
30. Thompson J. F. Kam P. C. A. de Wilt J. H. W. Lindner P. Isolated limb infusion for melanoma. In: Thompson JF, Morton DL, Kroon BBR, eds. Textbook of Melanoma. London, UK: Martin Dunitz; 2004:429-437.
31. Sankl A. Kam P. C. A. Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma. Ann Surg. 2007;4:591-596.
32. Lejeune F. J. Lienard D. el Douaihy M. Seyedi J. V. Ewalenko P. Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol. 1989;15:510-519. (Pubitemid 20037858)
33. Feldman A. L. Alexander H. R. Jr. Bartlett D. L. Fraker D. L. Libutti SK. Management of extremity recurrences after complete responses to isolated limb perfusion in patients with melanoma. Ann Surg Oncol. 1999;6:562-567. (Pubitemid 29428795)
34. Noorda E. M. Takkenberg B. Vrouenraets B. C. et al. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol. 2004; 11:491-499. (Pubitemid 40486730)
35. Thompson J. F. De Wilt JHW. Isolated limb perfusion in the management of patients with recurrent limb melanoma: an important but limited role. Ann Surg Oncol. 2001;8: 564-565. (Pubitemid 32928868)